Note 12 - Stockholders' Equity (Details) - Earnings (Loss) Per Share of Common Stock (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended				9 Months Ended
	Sep. 30, 2013		Sep. 30, 2012		Sep. 30, 2013		Sep. 30, 2012
Note 12 - Stockholders' Equity (Details) - Earnings (Loss) Per Share of Common Stock [Line Items]
Net loss (in Dollars)	$ (15,321)		$ (17,141)		$ (47,745)		$ (52,932)
Basic weighted average common shares outstanding	116,009,000		115,694,000		115,911,000		115,594,000
Incremental shares from assumed conversion of dilutive share based awards	0		0		0		0
Diluted weighted average common shares outstanding	116,009,000		115,694,000		115,911,000		115,594,000
Basic net loss per share (in Dollars per share)	$ (0.13)		$ (0.15)		$ (0.41)		$ (0.46)
Diluted net loss per share (in Dollars per share)	$ (0.13)		$ (0.15)		$ (0.41)		$ (0.46)
Antidilutive - Stock Option [Member]
Note 12 - Stockholders' Equity (Details) - Earnings (Loss) Per Share of Common Stock [Line Items]
Excluded Antidilutibe Securities	8,020,000	[1]	6,113,000	[1]	8,020,000	[1]	6,113,000	[1]
Convertible Notes 2017 [Member]
Note 12 - Stockholders' Equity (Details) - Earnings (Loss) Per Share of Common Stock [Line Items]
Excluded Antidilutibe Securities	35,878,000	[1]		[1]	35,878,000	[1]		[1]
2015 Convertible Notes [Member]
Note 12 - Stockholders' Equity (Details) - Earnings (Loss) Per Share of Common Stock [Line Items]
Excluded Antidilutibe Securities	14,516,000	[1]	28,890,000	[1]	14,516,000	[1]	28,890,000	[1]

[1] Inclusion of the shares for these awards would have had an antidilutive effect.